Bronwyn Lok

Ms. Bronwyn Lok

Universiti Sains Malaysia, Butterworth, Pulau Pinang, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2023 in Life
Verified
Journal Article
Open access
PDF file
BLBronwyn Lok
Bronwyn Lok
DBDinesh Babu
Dinesh Babu
YTYasser Mahfooth Tabana
Yasser Mahfooth Tabana
SDSaad Dahham
Saad Dahham
MAMowaffaq Adam Ahmed Adam
Mowaffaq Adam Ahmed Adam
DSDoblin Sandai
Doblin Sandai
The fruits, leaves, and bark of the guava (Psidium guajava) tree have traditionally been used to treat a myriad of ailments, especially in the tropical and subtropical regions. The various parts of the plant have been shown to exhibit medicinal properties, such as antimicrobial, antioxidant, anti-inflammatory, and antidiabetic activities. Recent studies have shown that the bioactive phytochemicals of several parts of the P. guajava plant exhibit anticancer activity. This review aims to present a concise summary of the in vitro and in vivo studies investigating the anticancer activity of the plant against various human cancer cell lines and animal models, including the identified phytochemicals that contributes to their activity via the different mechanisms. In vitro growth and cell viability studies, such as the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, the sulforhodamine B (SRB) assay, and the trypan blue exclusion test, were conducted using P. guajava extracts and their biomolecules to assess their effects on human cancer cell lines. Numerous studies have showcased that the P. guajava plant and its bioactive molecules, especially those extracted from its leaves, selectively suppress the growth of human cancer cells without cytotoxicity against the normal cells. This review presents the potential of the extracts of P. guajava and the bioactive molecules derived from it, to be utilized as a feasible alternative or adjuvant treatment for human cancers. The availability of the plant also contributes towards its viability as a cancer treatment in developing countries.

17 September 2020 in Medical Mycology
Verified
Journal Article
Closed access
BLBronwyn Lok
Bronwyn Lok
MAMowaffaq Adam Ahmad Adam
Mowaffaq Adam Ahmad Adam
LKLaina Zarisa Mohd Kamal
Laina Zarisa Mohd Kamal
NCNwakpa Anthony Chukwudi
Nwakpa Anthony Chukwudi
RSRosline Sandai
Rosline Sandai
DSDoblin Sandai
Doblin Sandai
Candida albicans is a commensal yeast commonly found on the skin and in the body. However, in immunocompromised individuals, the fungi could cause local and systemic infections. The carbon source available plays an important role in the establishment of C. albicans infections. The fungi's ability to assimilate a variety of carbon sources plays a vital role in its colonization, and by extension, its fitness and pathogenicity, as it often inhabits niches that are glucose-limited but rich in alternative carbon sources. A difference in carbon sources affect the growth and mating of C. albicans, which contributes to its pathogenicity as proliferation helps the fungi colonize its environment. The carbon source also affects its metabolism and signaling pathways, which are integral parts of the fungi's fitness and pathogenicity. As a big percentage of the carbon assimilated by C. albicans goes to cell wall biogenesis, the availability of different carbon sources will result in cell walls with variations in rigidity, adhesion, and surface hydrophobicity. In addition to the biofilm formation of the fungi, the carbon source also influences whether the fungi grow in yeast- or mycelial-form. Both forms play different roles in C. albicans’s infection process. A better understanding of the role of the carbon sources in C. albicans’s pathogenicity would contribute to more effective treatment solutions for fungal infections.

1 January 2020 in Asian Pacific Journal of Tropical Biomedicine
Verified
Journal Article
Closed access
PDF file
AMAms Abdul Majid
Ams Abdul Majid
BLBronwyn Lok
Bronwyn Lok
DSDoblin Sandai
Doblin Sandai
HBHussein M Baharetha
Hussein M Baharetha
VNV Mansoureh Nazari
V Mansoureh Nazari
CTChu Shan Tan
Chu Shan Tan
Objective: To evaluate the anti-angiogenic and anticancer activities of Psidium guajava leaf extracts against angiogenesis-dependent colorectal cancer. Methods: Three extracts were produced using distilled water, ethanol, and n-hexane as solvents. The extracts were physically characterised through gas chromatography–mass spectrometry, ultraviolet-visible spectroscopy, and Fourier transform infrared spectroscopy. Their antioxidant activity was evaluated using the 2,2-diphenyl-1-picrylhydrazyl, total phenolic content, and total flavonoid content assays. To assess their anti-angiogenic activity, cell viability and rat aortic ring assays were conducted, while cell migration, tube formation, colony formation, and VEGF ELISA assays were conducted to elucidate their effects on different aspects of angiogenesis. Molecular docking was used to assess the anti- angiogenic potential of some possible compounds in the extracts. Tumour spheroid assay was used to assess the extracts’ potential as a treatment for colorectal cancer. Results: The ethanol extract showed the best antioxidant activity. The distilled water and ethanol extracts exhibited more inhibitory activity against EA.hy926 cell viability and aortic ring microvessel growth. In addition, the ethanol extract performed significantly better than the distilled water extract against cell migration and colony formation, and VEGF expression of the cells was suppressed by the ethanol extract. Both the distilled water and ethanol extracts showed significant inhibitory effect on EA.hy926 tube formation and tumour spheroids consisting of EA.hy926 and HCT116 cells. The ethanol extract contained β-caryophyllene and β-elemene by phytochemical analysis and subsequent docking studies, which may contribute to its anti-angiogenic activity. Conclusions: The ethanol extract of Psidium guajava has potential in the treatment of colorectal cancer through the inhibition of angiogenesis.

Verified
Journal Article
Open access
PDF file
MAMowaffaq Adam Ahmed Adam
Mowaffaq Adam Ahmed Adam
LKLaina Zarisa Muhd Kamal
Laina Zarisa Muhd Kamal
MKMahibub Muhamadsa Muhamadsa Kanakal
Mahibub Muhamadsa Muhamadsa Kanakal
DBDinesh Babu
Dinesh Babu
SDSaad Dahham
Saad Dahham
DSDoblin Sandai
Doblin Sandai
The fungal toxin aflatoxin B1 (AB1) and its reactive intermediate, aflatoxin B1-8, 9 epoxide, could cause liver cancer by inducing DNA adducts. AB1 exposure can induce changes in the expression of several cancer-related genes. In this study, the effect of AB1 exposure on breast cancer MCF7 and normal breast MCF10A cell lines at the phenotypic and epigenetic levels was investigated to evaluate its potential in increasing the risk of breast cancer development. We hypothesized that, even at low concentrations, AB1 can cause changes in the expression of important genes involved in four pathways, i.e., p53, cancer, cell cycle, and apoptosis. The transcriptomic levels of BRCA1, BRCA2, p53, HER1, HER2, cMyc, BCL2, MCL1, CCND1, WNT3A, MAPK1, MAPK3, DAPK1, Casp8, and Casp9 were determined in MCF7 and MCF10A cells. Our results illustrate that treating both cells with AB1 induced cytotoxicity and apoptosis with reduction in cell viability in a concentration-dependent manner. Additionally, AB1 reduced reactive oxygen species levels. Phenotypically, AB1 caused cell-cycle arrest at G1, hypertrophy, and increased cell migration rates. There were changes in the expression levels of several tumor-related genes, which are known to contribute to activating cancer pathways. The effects of AB1 on the phenotype and epigenetics of both MCF7 and MCF10A cells associated with cancer development observed in this study suggest that AB1 is a potential risk factor for developing breast cancer.

20 January 2026 in Microbial Pathogenesis
Verified
Journal Article
Closed access
BLBronwyn Lok
Bronwyn Lok
NLNyok-Sean Lau
Nyok-Sean Lau
NMNoorizan Miswan
Noorizan Miswan
ASAlexander Chong Shu-Chien
Alexander Chong Shu-Chien
SSSiti Nurfatimah Mohd Shahpudin
Siti Nurfatimah Mohd Shahpudin
DSDoblin Sandai
Doblin Sandai

30 April 2017 in Journal of Angiotherapy
Verified
Journal Article
Closed access
PDF file
BLBronwyn Lok
Bronwyn Lok
AMAmin Malik Shah Abdul Majid
Amin Malik Shah Abdul Majid